Viyash Scientific Limited (NSE:VIYASH)

Market Cap	93.51B +87.4%
Revenue (ttm)	35.75B +123.1%
Net Income	2.11B +612.1%
EPS	4.75 +313.3%
Shares Out	n/a
PE Ratio	44.25
Forward PE	21.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,510,604
Open	222.39
Previous Close	221.11
Day's Range	204.26 - 222.88
52-Week Range	178.13 - 298.00
Beta	0.98
Analysts	Strong Buy
Price Target	326.00 (+52.64%)
Est. Earnings	Nov 4, 2026

About Viyash Scientific

Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary o...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 2,900
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIYASH

Financial Performance

In fiscal year 2026, Viyash Scientific's revenue was 34.20 billion, an increase of 13.75% compared to the previous year's 30.07 billion. Earnings were 1.77 billion, an increase of 663.53%.

Analyst Summary

According to 4 analysts, the average rating for VIYASH stock is "Strong Buy." The 12-month stock price target is ₹326.00, which is an increase of 52.64% from the latest price.

Price Target

₹326.00

(52.64% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 21, 2026

Data Sources Report a data error